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Class Switch Recombination and Hypermutation
Require Activation-Induced Cytidine
Deaminase (AID), a Potential RNA Editing Enzyme
Third, RNA editing creates new functional mRNAs
from the restricted genome in plants and protozoa (re-
viewed by Scott, 1995). Mammalian cells are also known
to edit an increasing number of mRNAs including those
for apolipoprotein (apo) B, glutamate receptors, Wilms
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tumor-1, a-galactosidase, and neurofibromatosis type-1†Department of Cell Biology
(reviewed by Smith and Sowden, 1996). A well-docu-Institute for Virus Research
mented mammalian RNA editing is apoB mRNA editingKyoto University
by a cytidine deaminase, APOBEC-1, together with itsKyoto 606-8501
accessory molecule (ACF), which modifies C to U at aJapan
specific site, and generates apoB100 and apoB48 pro-
teins from unedited and edited mRNA, respectively, with
different physiological functions (Teng et al., 1993;
Mehta et al., 2000).
Summary There are two additional types of genetic alteration in
the immune system, namely somatic hypermutation and
Induced overexpression of AID in CH12F3-2 B lym- class switch recombination (CSR) of the immunoglobulin
phoma cells augmented class switching from IgM (Ig) gene which take place in a highly specialized micro-
to IgA without cytokine stimulation. AID deficiency environment called the germinal center (Jacob et al.,
caused a complete defect in class switching and 1991; Liu et al., 1996). Somatic hypermutation accumu-
showed a hyper-IgM phenotype with enlarged germi- lates massive point mutations in the V exon and gives
nal centers containing strongly activated B cells be- rise to high-affinity antibodies for a given antigen in
fore or after immunization. AID2/2 spleen cells stimu- a process called affinity maturation, in which B cells
lated in vitro with LPS and cytokines failed to undergo expressing high affinity Ig on their surface are selected
class switch recombination although they expressed by limited amounts of antigens. Mutations are intro-
duced at a high frequency (1023–1024 per base division)germline transcripts. Immunization of AID2/2 chimera
at a defined region between the VH promoter and thewith 4-hydroxy-3-nitrophenylacetyl (NP) chicken g-glob-
intronic enhancer (reviewed by Wagner and Neuberger,ulin induced neither accumulation of mutations in the
1996). Studies using transgenic mice revealed that hy-NP-specific variable region gene nor class switching.
permutation does not depend on the defined sequenceThese results suggest that AID may be involved in
but on transcription of the target locus (Peters and Storb,regulation or catalysis of the DNA modification step
1996; Tumas-Brundage and Manser, 1997; Fukita et al.,of both class switching and somatic hypermutation.
1998). Although involvement of mismatch repair en-
zymes has been suggested, there are conflicting inter-Introduction
pretations (reviewed by Reynaud et al., 1999; Wabl et
al., 1999). Since fairly large deletion was also found inAlteration of genetic information is essential not only for
V regions of the stimulated B cells, the double-strandevolution but also for regulation of various physiological
DNA cleavage appears to be involved in hypermutationfunctions in living organisms. Accidental repair-medi-
(Goossens et al., 1998; Wilson et al., 1998).ated alteration aside, there are several systemic strate-
CSR replaces the Ig heavy chain constant region (CH)gies for living organisms to modify their genetic informa-
gene to be expressed from Cm to other CH genes, re-tion. Among these, the best characterized and most
sulting in switch of the Ig isotype from IgM to eitherwidely distributed is the homologous recombination,
IgG, IgE, or IgA. Each isotype determines the mannerwhich depends on the sequence homology between
whereby captured antigens are eliminated or the loca-target DNA regions, and is known to take place often
tion where Ig is delivered and accumulated. The Ig CHduring meiosis, as well as in somatic cells (Sonoda et
locus consists of the ordered array of CH genes, eachal., 1999; reviewed by Haber, 1999). A second type of
flanked at its 59 region by an S region which is composedgenetic modification is mediated by site-specific recom-
of tandem repetitive unit sequences with many palin-bination which requires defined sequences recognized
dromes (reviewed by Zhang et al., 1995). CSR takesby specific recombinases. The immune system utilizes
place between two broad areas surrounding S regions,this mechanism to generate antigen recognition diver-
resulting in looped-out deletion of intervening DNA seg-sity. VDJ recombination assembles the variable (V), di-
ments (Iwasato et al., 1990; Matsuoka et al., 1990; vonversity (D), and joining (J) segments to form a V exon of
Schwedler et al., 1990). Since the Cm gene is located atthe antigen receptor genes in the early phase of lympho-
the VH proximal end of the CH gene cluster, CSR betweencyte differentiation and is mediated by two proteins,
Sm and another S region 59 to a CH gene brings thatRAG-1 and RAG-2, which bind to and cleave the specific
particular CH gene adjacent to the VH exon. Target speci-recognition sequence of DNA. Subsequently, cleaved
ficity of CSR is not determined by the primary sequenceends are joined together by the end joining repair system
of the S region (Kinoshita et al., 1998), but rather byused in general recombination machinery (reviewed by
chromatin opening (accessibility) of the target region,Gellert, 1997; Oettinger, 1999).
which is regulated by cytokine-induced transcription
from the specific I promoter located 59 to each S region‡ To whom correspondence should be addressed (e-mail: honjo@
mfour.med.kyoto-u.ac.jp). (Stavnezer and Sirlin, 1986; Yancopoulos et al., 1986).
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Synthesis of so-called germline transcripts by this tran-
scription and subsequent splicing from an I exon to its
downstream CH exons is required to precede CSR (Gu
et al., 1993; Jung et al., 1993; Xu et al., 1993; Hein et
al., 1998). Since the end-joining repair system is involved
in CSR (Rolink et al., 1996; Casellas et al., 1998; Manis
et al., 1998), double strand cleavage of S regions ap-
pears to be required for CSR. CSR is distinct from ho-
mologous recombination because there are generally no
homologous sequences at recombination breakpoints
(Nikaido et al., 1982; Dunnick et al., 1993; Lee et al.,
1998) and Rad54 deficiency does not affect CSR (Essers
et al., 1997). Taken together, two critical pieces of infor-
mation are commonly missing for the molecular mecha-
nism of hypermutation and CSR; DNA cleaving enzyme
and its recognition target.
To understand the molecular mechanism of CSR, we
have developed an in vitro assay system using artificial
DNA constructs and murine lymphoma cells (CH12F3-2),
more than 80% of which switch from IgM1 almost
exclusively to IgA1 in one week after stimulation with
CD40L, IL-4, and TGFb (Nakamura et al., 1996). DNA
constructs introduced into CH12F3-2 cells contain Sm
and Sa regions that are constitutively transcribed by
separate promoters. CSR takes place in the transgene
as well as the endogenous Ig locus only when the trans-
fected CH12F3-2 cells are stimulated with CD40L, IL-4,
and TGFb (Kinoshita et al., 1998). Since the transgene
Figure 1. Induced Expression of AID in CH12F3-2 Cellslocus is constitutively transcribed and thus accessible
Clone numbers indicate independent transfectants with AID-to a putative CSR recombinase, we assumed that the
expressing vector (1, 4, and 5) or mock vector (17, 20, and 22).stimulation requirement for transgene CSR could be due
(A) RNase protection assay using 5 mg of total RNA from indicatedto induction of a new protein, most likely CSR recombi-
transfectants cultured in the presence (1) or absence (2) of tet. Thenase. This assumption was partially supported by CSR
same amount of yeast RNA was used as control.
inhibition with the addition of cycloheximide to culture (B) Frequencies of IgA1 cells were measured by FACS before (non-
media of CH12F3-2 cells (Muramatsu et al., 1999). We stimulated) and 24 hr (stimulated) after stimulation. Experiment was
therefore carried out cDNA subtraction between stimu- performed in triplicate and mean values (bars) with standard devia-
lated and nonstimulated CH12F3-2 cells, and identified tions are shown. All transfectants expressed similar levels of germ-
line Ca transcripts. Similar results were obtained from at least threea novel member of the RNA editing cytidine deaminase
independent experiments.family, activation-induced cytidine deaminase (AID)
which is specifically expressed in germinal center B cells
(Muramatsu et al., 1999). AID is also induced in spleen
the removal of tet (Figure 1A). Endogenous AID mRNA
B cells by in vitro stimulation with IL-4 and lipopolysac-
was detectable only by RT-PCR without stimulation
charide (LPS) or CD40L. (data not shown). The transfectants were stimulated to
In the present study, we show that induced overex- switch from IgM to IgA with the suboptimal concentra-
pression of AID in CH12F3-2 cells augmented class tions of CD40L, IL-4, and TGFb (Figure 1B, right). Under
switching from IgM to IgA without cytokine stimulation. these conditions, AID induction by the removal of tet
We also demonstrate that the AID deficiency completely enhanced class switching of CH12F3-2 cells 2–5 fold.
blocked CSR in B cells although they are activated by It is worth noting that AID expression alone induced
LPS in vitro as well as antigens in vivo. To our surprise, class switching significantly, albeit weakly, in CH12F3-2
somatic hypermutation was also abrogated in immu- cells (Figure 1B, left). These results provide gain-of-
nized AID2/2 B cells, indicating that class switching and function evidence for the involvement of AID in class
hypermutation depend on a common molecular mecha- switching.
nism at least in part.
Generation of AID-Deficient Mice
To confirm involvement of AID in class switching in vivo,
Results we have disrupted the gene encoding AID in a TT2 ES
cell line using a target vector shown in Figure 2A. The
Stimulation of Class Switching by AID Induction targeting vector was introduced into the ES line, and
in CH12F3-2 B Cells clones with homologous integration of the construct
To examine whether AID is involved in CSR, we trans- were selected by PCR screening. Southern blot hybrid-
fected CH12F3-2 cells with the AID cDNA directed by an ization confirmed a homologous integration of the target
inducible tetracycline (tet) promoter. Three independent vector in ES cells (Figure 2B), which is expected to re-
transfectants were examined for stimulation of class place exon 2 and the 59 half of exon 3 (encoding the
switching upon AID induction. We first confirmed that cytidine deaminase motif) of the AID gene with the
neomycin resistance (NeoR) gene. The heterozygouslyAID mRNA was in fact induced in the transfectants by
AID Requirement for Class Switch and Hypermutation
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The Absence of Class Switching in AID-Deficient
B Cells
The most obvious sign of class switching defect would
appear in the serum Ig levels even without active immu-
nization. Serum levels of IgM, IgG, and IgA in AID2/2
mice were quantitated at 10 weeks of age. As shown in
Figure 3A, there were no detectable levels of IgG3,
IgG2b, and IgA in AID2/2. Serum IgG1 and IgG2a levels in
these mice were less than one tenth of those in AID1/2.
Similar levels of IgG1 and IgG2a are also found in
AID2/2 chimera and these residual IgGs are most likely
to be derived from maternal blood but not from AID2/2
B cells because (1) IgG1 levels in AID2/2 chimera de-
creased to one-tenth in a 5 week interval between 7 and
12 weeks and (2) IgG1 molecules detected in AID2/2
chimera and its ICR mother have the same allotype a,
while IgG1 from wild-type TT2 ES cell-derived B cells
have a/b allotypes as detected by allotype-specific
monoclonal antibodies (data not shown). On the other
hand, serum IgM levels of AID2/2 were slightly (2–3 fold)
elevated as compared with those of AID1/2 mice.
To examine whether AID deficiency in lymphocytes
causes defects of Ig production upon antigen stimula-
tion, we immunized AID2/2 chimera by two intraperito-
neal injections of sheep red blood cells (SRBC) with a
14 day interval. Serum Ig levels specific to SRBC were
Figure 2. Generation of AID-Deficient Mice and AID2/2 Chimera measured by ELISA at various time points. As shown in
(A) Schematic representation of the wild type and mutant genomic Figure 3B, AID2/2 chimera showed no IgG1 antibody
AID loci together with the target vector. Restriction enzyme sites production against SRBC, whereas significant amounts
(X, XhoI; Ps, PstI; Bss, BssHII; and Pv, PvuI), the probe for Southern of SRBC-specific IgG1 antibodies were produced in
blot analysis (solid bar), and primer sites (arrowheads) are indicated. AID1/2 chimera. In contrast, SRBC specific IgM levels
PstI fragments detected by the probe are shown for wild-type and were comparable between AID2/2 and AID1/2 chimeras.
targeted alleles. Exons are represented by open boxes. Cytidine
These results suggest that AID2/2 B cells have a severedeaminase motif regions in exon 3 are shown by a closed box. TK,
defect in class switching although they can producethymidine kinase.
antigen-specific IgM in response to T-dependent anti-(B) Southern blot analysis of PstI-digested DNA prepared from wild-
gens (SRBC).type, single, and double knockout ES cells (right panel) or tails of
progenies by mating a heterozygote pair (left side).
(C) Absence of AID transcripts in AID-deficient B cells. Spleen cells Normal Development and Hyperactivation
from AID1/1, AID1/2 , and AID2/2 mice were cultured with LPS for
of AID-Deficient IgM1 B Cellstwo days. Deletion of cytidine deaminase motif sequence in AID
FACS analysis of bone marrow, thymus, and peritonealtranscripts was examined by RT-PCR with primer sets (119 and 118).
cavity of AID2/2 mice as well as AID2/2 chimera showedRNAs from MLN of AID1/2 or AID2/2 chimera were also examined.
no obvious difference of B, T, and other hematopoietic
cells as compared with AID1/2 mice (data not shown).
Peripheral, mature AID2/2 B cells expressed both IgM
AID-disrupted ES cells were injected into ICR 8-cell em- and IgD (data not shown). When lymphocytes from Pey-
bryos. Founder animals were crossed into C57BL/6 er’s patches, MLN, and spleen were stained for surface
background and mated to generate AID2/2 mice. Figure Ig expression, we found no IgG1 B cells in AID2/2 chi-
2B shows the AID genotypes of progenies from one mera before or after immunization, while the number of
heterozygote mating. Some of the ES cells were cultured IgG1 B cells increased in AID1/2 chimera after SRBC
in the presence of high concentrations of G418 to facili- immunization (Figure 4 and data not shown). By con-
tate homozygous disruption of the AID gene. AID2/2 ES trast, surface expression of IgM was higher in AID2/2
cells were injected into RAG-22/2 8-cell embryos, giving than AID1/2 chimera, particularly in Peyer’s patches and
rise to chimeric animals in which any mature lympho- MLN either before or after immunization (Figure 4). More-
cytes must be derived from the injected ES cells be- over, the surface expression of several activation mark-
cause RAG-2 deficient mice fail to rearrange the antigen ers, such as MHC class II, CD69, or CD86 was higher
receptor genes and thus have no mature T and B cells in AID2/2 than AID1/2 chimera regardless of SRBC immu-
(Chen et al., 1993). We have confirmed that normal AID nization (Figure 4 and data not shown). Similarly, Peyer’s
transcripts are absent in the homozygous mutant of the patches, MLN, and spleen of AID2/2 chimera contained
AID gene by RT-PCR (Figure 2C). Spleen cells of AID2/2 more B cells expressing peanut agglutinin (PNA) recep-
mice stimulated in vitro with LPS and mesenteric lymph tor, another activation marker specific to germinal cen-
node (MLN) cells of AID2/2 chimera were completely ters, before and after SRBC immunization. In contrast,
depleted of AID mRNA expression whereas AID1/2 lym- PNA1 B cells were very few in inguinal lymph nodes (ILN)
phocytes expressed AID mRNA as reported previously of AID2/2 and AID1/2 chimera even after immunization
(Muramatsu et al., 1999). We studied both AID2/2 chi- (Figure 4). These results indicate that AID2/2 IgM1B cells
mera and AID2/2 mice and they showed similar pheno- develop normally, are activated more strongly, and ac-
cumulate more after antigenic stimulation than AID1/2types as far as examined.
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Figure 3. Absence of Class Switching in AID-Deficient B Cells
(A) Sera from 10-week old AID2/2 (open circle) and age-matched AID1/2 (closed circle) mice were collected and their Ig levels were determined
by ELISA. Ig levels less than 0.01 mg/ml were plotted below the base lines.
(B) AID2/2 (open circle) or AID1/2 (closed circle) chimeras were immunized with 1 3 108 SRBC on day 0 and 14 (arrows). Anti-SRBC IgM or
IgG1 serum levels were measured at day 0, 5, 10, 14, and 21. Arbitrary unit is absorbance at OD405nm. Similar results were obtained from two
independent experiments.
(C) Ig levels of culture supernatants of spleen cells from 5-week old littermates (AID1/1, AID1/2 , and AID2/2) mice were measured after culture
for 7 days in the presence of LPS (closed circle), LPS and IL-4 (open circle), or LPS and TGFb (open square). Ig levels less than 0.01 mg/ml
were plotted below the base lines.
IgM1 B cells, although AID-deficient B cells have the kines. First, culture supernatants of AID2/2 spleen cells
stimulated with LPS in the presence or absence of IL-4defect in class switching.
were analyzed for their contents of Ig by ELISA. AID2/2Immunohistochemical analyses of spleen in nonim-
supernatants contained comparable amounts of IgMmunized or immunized AID2/2 chimera indicate the pres-
with those of littermates (AID1/1 and AID1/2) but did notence of large numbers of IgM1PNA1-activated B cells,
contain any other isotypes of Ig including IgG1, IgG2a,widely spread in lymphoid follicles, which themselves
IgG2b, IgG3, IgE, and IgA (Figure 3C). The absence ofexpand enormously (Figures 5A–5F). The formation of
class switching to IgG2b and IgA persisted even whengerminal centers was clear and the structure appeared
the cytokine was changed to TGFb. On the other hand,to be retained with mucosal addressin cell adhesion
supernatants of AID1/1 and AID1/2 spleen cells stimu-molecule-1 (MAdCAM-1) expressing marginal sinus; fol-
lated under the same condition contained comparablelicular dendritic cells in AID2/2 chimera spleen were dif-
levels of IgM, IgG, IgE, and IgA, which varied dependingfusely spread in lymphoid follicles in parallel with en-
on the presence or absence of cytokines. The absencelargement of germinal centers (Figures 5G, 5H, 5K, and
of class switching was also confirmed by FACS analysis5L). As expected, IgG1 B cells or plasma cells were not
(data not shown).detected in spleen of AID2/2 chimera, whereas those of
The defect of CSR was also demonstrated by theAID1/2 chimera were clearly observed (Figures 5I and 5J).
absence of class-specific mRNA as well as DNA re-These immunohistochemical examinations together with
arrangement of the Ig locus. Since the Im promoter isFACS analysis showed enhanced germinal center forma-
active in all mature B cells, including those after classtion and hyperactivated features of IgM1 B cells in spleen
switching, transcripts composed of the Im exon splicedof nonimmunized as well as immunized AID2/2 chimeras
onto the 59 exon of a CH gene other than Cm are gener-consistent with their elevated serum IgM levels.
ated after switching to that particular CH gene (Li et
al., 1994). As shown in Figure 6A, AID2/2 spleen cells
Defect of Class Switch Recombination stimulated with LPS in the presence or absence of IL-4
in AID-Deficient B Cells Stimulated or TGFb did not express any of Im-Cg1, Im-Cg2a, Im-
In Vitro Cg2b, Im-Cg3, Im-Ce , or Im-Ca transcripts, demonstrating
To further confirm that the absence of Ig class switching that AID deficiency resulted in the complete absence of
in AID-deficient B cells is due to the defect of the CSR class switching. Control spleen cells of AID1/1 or AID1/2
machinery and not B cell activation, we analyzed spleen mice generated expected classes of Im-CH transcripts,
depending on the presence or absence of the cytokines.cells of AID2/2 mice after stimulation with LPS and cyto-
AID Requirement for Class Switch and Hypermutation
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Figure 4. FACS Analysis of AID2/2 Chimera
Flow cytometric analysis of Peyer’s patch, MLN, ILN, and spleen cells derived from nonimmunized (N) and immunized (I) AID2/2 and AID1/2
chimeras. Immunization was done as described in Figure 3B. 2 3 104 cells were analyzed for expression of B220 or CD19 in combination with
IgM, IgG, CD69, MHC class II, or PNA. Percentages of gated cells are shown. Mean fluorescence intensities (MFIs) of IgM, CD69, and MHC
class II of total B cells are shown in parentheses.
Cell
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Figure 5. Immunohistochemical Analysis of AID2/2 Chimera
Serial sections of spleens were prepared from nonimmunized (A and B) and SRBC-immunized (day 21, C–L) mice; AID2/2 (B, D, F, H, J, and
L) and AID 1/2 (A, C, E, G, I, and K). Immunofluorescence microscopic study was performed to detect germinal centers (A–F; PNA-FITC, anti-
IgM-Texas Red), development of follicular dendritic cell networks (G and H; FDC-M1-FITC, anti-IgM-Texas Red), marginal zone lining cells (K
and L; MAdCAM-1-FITC) and IgG plasma cells (I and J; anti-IgG-FITC, anti-IgM-Texas Red). Scale bars, 200 mm.
To directly examine DNA rearrangement in the Ig locus, examined whether the AID deficiency affects the effi-
ciency of hypermutation. AID2/2 chimeras were immu-we carried out digestion-circularization (DC) PCR of
DNA obtained from spleen cells stimulated with LPS nized with NP-conjugated chicken g-globulin (CGG).
After two intraperitoneal injections of the antigen withand IL-4 or TGFb (Chu et al., 1992). As shown in Figure
6C, m2g1 and m2g2b DC-PCR products were clearly a 3 week interval, the NP-specific IgM antibody titer was
slightly higher in sera of AID2/2 chimera than those ofamplified in stimulated spleen cell DNA of AID1/1 and
AID1/2 but not of AID2/2 mice. The results show that the AID1/2 chimera. However, no anti-NP IgG1 was pro-
duced by AID2/2 chimera (Figure 7A). MLN RNA wasAID deficiency abolished the CSR activity of B cells.
We have also examined the expression of germline extracted from AID1/2 and AID2/2 chimeras and VH186.2-
Cm (or Cg1) cDNA segments were amplified by RT-PCR totranscripts directed by the I promoter of each isotype,
which is required to precede CSR upon B cell stimula- determine their nucleotide sequences. AID1/2-derived
VH186.2 sequences of the m and g1 chains carried com-tion. AID2/2 spleen cells expressed germline transcripts
of all the isotypes in response to LPS with and without parable levels of mutation in the total and framework re-
gions (Table 1). However, CDR of the AID1/2 g1 chain con-cytokines in a similar manner to AID1/1 and AID1/2
spleen cells (Figure 6B). The germline transcripts were tained a 60% higher frequency of mutations than that
of the AID1/2 m chain. R/S ratios were higher in CDR thanof expected sizes for appropriately spliced forms, and
their amounts were similar among all AID genotypes as framework region of both m and g1 chains of AID1/2
assessed by serial 3-fold dilution of cDNA (data not VH186.2 sequences. Furthermore, AID1/2 VH186.2 se-
shown). These results taken together indicate that AID quences of the g1 chain contained, more frequently than
deficiency causes defect in the CSR machinery per se those of the m chain, the characteristic mutation at 33Trp
that plays a role after target S regions become accessi- (TGG) to 33Leu (TTG), which is known to be responsible
ble by germline transcription from I promoters. for high-affinity binding to the NP hapten (Figure 7B and
data not shown) (Allen et al., 1988). By contrast, AID2/2
m chains contained 10 times fewer mutations thanThe Defect of Hypermutation in AID-Deficient B Cells
Since CSR is often but not always coupled with hyper- AID1/2 m chain (Table 1). There were no mutations in
CDR 1 and CDR 2 of the AID2/2 VH186.2 m chain. Themutation in the VH exon after antigen stimulation, we
AID Requirement for Class Switch and Hypermutation
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Figure 6. The Absence of CSR in AID-Defi-
cient B Cells Stimulated In Vitro
Spleen B cells from 5-week old AID1/1, AID1/2,
and AID2/2 mice were stimulated in vitro with
LPS alone, LPS and IL-4, and LPS and inter-
feron-g (g2a), or LPS and TGFb (g2b, a) for
2 (B) or 4 (A and C) days. Controls without
stimulation were harvested at day 0. Water,
without cDNAs. HPRT, hypoxanthine phos-
phoribosyltransferase, cDNA control.
(A) RT-PCR of postswitch transcripts con-
taining Im and each of CH exons. Schematic
representation of Im-Cx transcripts is shown
at the top.
(B) RT-PCR of germline transcripts containing
I and CH exons of the same isotype. Among
three kinds of alternatively spliced forms of
a germline transcripts, only 497 and 357 bp
species are shown.
(C) DC-PCR assay of genomic DNA from stim-
ulated B cells.
mutation frequency (1.5 3 1023) of AID2/2 VH186.2 se- (HIGM2), in which not only was class switching com-
pletely blocked, but also that hypermutation was ex-quences was comparable to that due to PCR by Taq
polymerase (manufacturer’s data). These results indi- tremely low in IgM antibodies. We found that all the
patients of HIGM2 have mutations at the various posi-cate that AID2/2 B cells are defective, not only in CSR,
but also in hypermutation. tions in the AID gene (Revy et al., 2000 [this issue of
Cell]), indicating that AID2/2 mouse phenotypes de-
scribed here are not due to artifacts of the neomycin
Discussion gene integration.
CSR in B cells can be affected by the defects of either
AID was isolated by cDNA subtraction from CH12F3-2 extracellular stimulation, intracellular signal transduc-
cells which can be induced to switch efficiently from tion, or nuclear events. The AID deficiency does not
IgM to IgA by stimulation with CD40L, IL-4, and TGFb appear to affect maturation of B cells and other cell
(Muramatsu et al., 1999). AID is induced not only in types that regulate B cell activation, as shown by FACS
stimulated CH12F3-2 cells but also in LPS-stimulated and immunohistochemical studies (Figures 4 and 5). Sig-
spleen B cells, and expressed in germinal centers of nal transduction from the B cell antigen receptor ap-
antigen-stimulated spleen and Peyer’s patches. We pears to be functional in AID2/2 mice because there
have shown that AID induction by the tet-inducible pro- are many signs of activation of B cells before or after
moter in CH12F3-2 cells augmented class switching immunization. In addition, AID deficient mice can pro-
even in the absence of cytokine stimulation (Figure 1). duce antigen specific IgM in response to the T-depen-
AID deficiency causes the complete absence of class dent antigens (Figures 3 and 7). These phenotypes are
switching in mice before or after immunization with in a contrast to those of X-linked hyper-IgM syndrome
T-dependent antigens (Figures 3 and 7). In addition, patients, in which the CD40L mutation causes the loss
AID2/2 spleen B cells stimulated in vitro with LPS and of germinal center formation and Ig production in re-
cytokines can not undergo CSR (Figure 6). Surprisingly, sponse to T-dependent antigens. This mutation, how-
AID deficiency also abrogates hypermutation of the spe- ever, does not affect class switching by in vitro culture
cific VH gene in response to NP-conjugated, T-depen- of B cells with appropriate stimulation (Allen et al., 1993;
dent antigen immunization (Figure 7 and Table 1). In the Aruffo et al., 1993; DiSanto et al., 1993; Korthauer et al.,
accompanying paper (Revy et al., 2000 [this issue of 1993). In fact, AID-deficient mice is the first case in which
Cell]), we report that an essentially similar conclusion is class switching is completely blocked despite intact ger-
minal center formation. These results indicate that AIDdrawn by the analysis of a human hyper-IgM syndrome
Cell
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Figure 7. Defect of Hypermutation in AID2/2
Chimera
(A) Primary and secondary responses against
NP in AID2/2 chimera. Anti-NP IgM and IgG1
levels were measured 0, 7, 14, and 28 days
after AID2/2 (open circle) or AID1/2 (closed
circle) chimeras were immunized with NP-
CGG intraperitonealy on day 0 and 21
(arrows). Each circle represents an arbitrary
unit (absorbance at OD405 nm) of a single
mouse.
(B) Mutation frequencies in the VH186.2 tran-
scripts from MLN of NP-immunized AID2/2
and AID1/2 chimeras. VH186.2 transcripts of
m and g1 isotypes at day 28 were amplified
by RT-PCR and cloned into a plasmid vector
before sequencing. Six clones of g1 isotype
from AID1/2 chimera, and 17 and 16 clones
of m isotype from AID1/2 and AID2/2 chimeras,
respectively, were sequenced. Mutation fre-
quency of clones that have amino acid re-
placements (closed bar) or silent mutation
(open bar) at specific position was plotted
along residue number from 211 to 98.
is involved in neither development nor activation of B are several candidates, such as the error-prone repair
system (Ni et al., 1999), the low-fidelity DNA polymerasecells, but more specifically in a step of CSR. AID appears
to play a role in DNA cleavage because (1) AID deficiency family (reviewed by Friedberg et al., 2000), and muta-
tions associated with double-strand break repair (Hol-does not affect germline transcription of target DNA
(Figure 6), (2) AID induction augments class switching beck and Strathern, 1997).
FACS and immunohistochemistry data suggest accu-of CH12F3-2 cells, which are known to express germline
transcripts even without stimulation (Nakamura et al., mulation of AID2/2 B cells upon stimulation. Increase in
activated IgM1 B cells in AID2/2 mice is probably not due1996) and (3) AID deficiency does not affect VDJ recom-
bination, which includes the end joining repair system. to the cell autonomous defect of cell cycle regulation
because (1) the fraction of PNA1 B cells is very low inIt is unexpected that a single gene mutation of AID
abolishes both CSR and hypermutation. It has been ILN of AID2/2 chimera in which B cells are exposed to
much less antigen injected into the peritoneal cavityshown that the VH region of IgM can also contain hyper-
mutation, indicating that class switching is not required than those in MLN, and (2) AID2/2 and AID1/2 spleen
cells proliferate comparably when cultured with or with-for hypermutation (Mantovani et al., 1993; Sohn et al.,
1993). However, this observation does not exclude the out LPS in vitro (see Supplementary Data). Apparent
hyperproliferation of IgM1 B cells was also seen inpossibility that a single molecule is involved in both
reactions. Although our knowledge about other mole- HIGM2 patients (Revy et al., 2000 [this issue of Cell]).
It is possible that class switching or hypermutation iscules involved in hypermutation is very limited, there
Table 1. Somatic Mutations in Rearranged VH186.2 Sequences in AID2/2 Chimerasa
Total number of Mutation 3 103 per baseb
Chains Total (327 bp) CDR112 (66 bp) Framework (228 bp)
H chain
(AID) Sequenced Mutated Bases Total Rc Sc R/Sc Total R S R/S Total R S R/S
a1(1/2) 7 6 2289 16 10 6.1 1.6 46 39 6.5 6.0 10 3.1 6.9 0.5
m(1/2) 17 11 5559 13 9.9 3.2 3.1 28 24 3.6 6.8 11 7.2 3.6 2.0
m(2/2) 16 6 5232 1.5 1.1 0.4 3.0 0.0 0.0 0.0 — 2.2 1.6 0.5 3.0
a Nucleotide exchange frequency in the VH186.2 segments of g1 and m transcripts. Nucleotide replacements at the VHDH junctions were not
scored as mutations. Dinucleotide replacements in a codon were counted as one.
b Mutation frequency was calculated by dividing the accumulated number of mutations in a given region with the total number of nucleotides
sequenced for the region, length of which is shown in parentheses.
c R and S stand for replacement and silent mutations, respectively. R/S indicates ratio of replacement to silent mutations.
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surrounding the termination codon of AID. Mouse b-actin probecoupled with negative feedback signal for stimulation-
(157 bp) was also prepared by PCR.induced proliferation of B cells so that activated B cells
can differentiate.
Target Vector, Generation of AID-Deficient Mouse,AID is not only structurally related to APOBEC-1, RNA
and RAG-22/2 Blastocyst Complementationediting cytidine deaminase, but also functionally similar
Genomic DNA containing the AID locus was isolated from a 129in its cytidine deaminase activity (Muramatsu et al.,
SvJ genomic library (Stratagene). Ten kb XhoI fragment and 1.8 kb
1999). AID was mapped to the locus close to that of BssHII/PvuI fragment of AID gene were ligated to SalI and XhoI sites
APOBEC-1 on human chromosome 12p13, suggesting of pLNTK (Gorman et al., 1996), respectively. The linearized target
that these two genes were generated by recent duplica- vector was transfected into TT2 ES cells (C57BL/6 3 CBA F1 origin)
tion (Muto et al., 2000). The most straightforward possi- as previously described (Yagi et al., 1993). Five clones with homolo-
gous recombination were isolated by PCR screening using G3 andbility for the function of AID is, therefore, an RNA editing
203 primers, and confirmed by Southern blot analysis using the 39enzyme with a substrate specificity determined by an
external probe (Figure 2). Founder mice generated by injection ofadditional co-factor like ACF for APOBEC-1 (Mehta et
AID1/2 ES clones into 8-cell embryos of ICR mice were mated withal., 2000). In that case, mRNA encoding an unknown
C57BL/6 mice and their germline transmission was confirmed byprotein might be converted to that for CSR recombinase
Southern blot analysis as shown in Figure 1B. Double knockout ES
and hypermutator by the function of AID and its cofactor. cells were isolated in almost the same way as described elsewhere
In fact, CSR and hypermutation may share a part of the (Cogne et al., 1994). AID1/1, AID1/2, and AID2/2 TT2 clones were
genetic alteration machinery because frequent muta- injected into 8-cell embryos of RAG-2 deficient mouse (C57BL/6
tions are reported in the vicinity of CSR breakpoints background) and transplanted to foster mothers (ICR) (Yagi et al.,
1993). All of the AID1/2 and AID2/2 chimeras used in this study(Dunnick et al., 1993; Lee et al., 1998), and frequent large
showed almost 100% ES contribution as determined by their coatdeletions have been reported in the V region (Goossens
color. Mice were bred in specific pathogen free conditions.et al., 1998; Wilson et al., 1998). Obvious candidates of
the AID target may be the DNA repair enzymes, DNases,
Immunization and Determination of Ig Titersand DNA polymerases discussed above. It is also possi-
Eight- to twenty-week old mice were immunized by intraperitonealble that AID associates with different accessory mole-
injection of 1 3 108 SRBC or 100 mg NP-CGG (23:1) (Biosearch
cules to recognize different target mRNAs; one for CSR Technologies) mixed with alum. Levels of anti-SRBC and anti-NP
and the other for hypermutation. Although less likely, antibodies were determined by ELISA using soluble SRBC (Kelly et
AID may edit DNA directly or edit RNA to generate a al., 1979) and NP-BSA (23:1) (Biosearch Technologies), respectively,
ribozyme that can alter genetic information of the Ig as a capture agent. To measure secreted Ig, red blood cell–depleted
spleen cells (5 3 105 /ml) were cultured for 3 days in 2 ml of mediumlocus.
(Burstein et al., 1991) containing 50 mg/ml LPS (Sigma), LPS 1 10 ng/CSR has several unique properties as compared to
ml murine IL-4 (Life Technology), LPS 1 10 U/ml mouse interferon-goher known recombination systems: (1) CSR target se-
(Genzyme), or LPS 1 1 ng/ml human TGFb (R&D). After serial dilutionquences are not clear except that repetitive palindromic
of samples to find the linear range, Ig levels were determined byS regions are required (Kinoshita et al., 1998), (2) germ-
ELISA as described previously (Nishimura et al., 1998) except that
line transcription and splicing are essential (Gu et al., rat anti-mouse e chain monoclonal antibody (PharMingen) and goat
1993; Jung et al., 1993; Xu et al., 1993; Hein et al., 1998), anti-mouse m chain specific antibody (Southern Biotechnology)
and (3) transcription orientation of two S regions deter- were used to determine IgE and IgM respectively.
mines recombination products, i.e., deletion and inver-
sion by the same and opposite orientations, respectively Flow Cytometry Analysis
The following monoclonal antibodies were used. Fluorescein iso-(Kinoshita et al., 1999; reviewed by Kinoshita and Honjo,
thiocyanate (FITC)-conjugated antibodies; anti-B220 (RA3-6B2) and2000). The present study suggests that RNA editing may
anti I-Ab (Abb) (AF6-120.1) (PharMingen). PE-conjugated antibodies;be involved in CSR and hypermutation either directly
anti-CD19 (1D3) and anti-CD69 (H1.2F3) (PharMingen). Polyclonalor indirectly, adding yet another unique and complex
antibodies; FITC-conjugated; anti-IgG (Southern Biotechnology).feature to CSR and hypermutation. This would be the
PE-conjugated; anti-IgM (Southern Biotechnology). FITC-conju-
first case in which two different genetic alteration sys- gated PNA (Vector). All analyses were performed on a FACSCali-
tems (RNA editing and CSR or hypermutation) cooperate burÆ (Becton Dickinson). Data were obtained on 2 3 104 viable
for a given biological function. Although we have pro- cells, as determined by forward light scatter intensity and propidium
vided the evidence that AID is the essential component iodide gatings.
for both CSR and hypermutation, their molecular mecha-
Immunohistochemical Examinationnisms still remain to be solved.
Tissue samples from spleen of nonimmunized or immunized mice
were frozen in tissue-tek O.C.T. compound (Sakura Finetechnical).Experimental Procedures
Tissue sections (6 mm thick) were prepared and fixed in a fresh
solution of 4% paraformaldehyde for 15 min. Cells were stainedInduced Expression of AID in CH12F3-2 Cells
using the following reagents: anti-IgM-Biotin (Cappel), anti-PNA-An AID expression vector with tet-responsive promoter (GIBCO BRL)
FITC (Vector), anti-FDC-M1 (rat anti-mouse, gift from Dr. M. Kosco-and IRES-EGFP segment (Clontech) was introduced to CH12F3-2
Vilbois), anti-IgG-FITC (Southern Biotechnology), anti-MAdCAM-1cells that had been previously transfected with a construct express-
(rat anti-mouse MECA-367; PharMingen), streptavidin-Texas Reding tet-responsive transactivator (tTAk, GIBCO BRL) driven by tet
(Gibco BRL), and goat anti-rat IgG-FITC (Cappel). The sections werepromoter. To suppress AID expression, 0.5 mg/ml of tet was used.
mounted in Immunon (Shandon). Slides were analyzed with a Bio-Transfectants that upregulate EGFP one day after removal of tet
Rad confocal laser scanning microscope (model MRC-1024).were stimulated with the half dose of CD40L, IL-4, and TGFb required
for the optimal induction of IgA switching (Nakamura et al., 1996).
Stimulated cells are analyzed 24 hr later by FACS after staining RT-PCR
Total RNA was extracted from spleen cells of AID2/2 mice culturedwith phycoerythrin (PE)-conjugated goat anti-mouse IgA antibody
(Southern Biotechnology). At the same time, total RNA was ex- in vitro and MLN of AID2/2 chimeras using TRIzol (Gibco BRL) ac-
cording to manufacturer’s instructions. For amplification of AID tran-tracted from cells and amount of AID transcripts was analyzed by
RNase protection assay using the RPA II kit (Ambion). The template scripts, 119 and 118 primer pairs were used in 30 cycles of PCR.
For PCR of germline transcripts, the following primers were usedof RNA probe was prepared by PCR and contains a 196 bp region
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to obtain indicated sizes of products: (m) ImF and CmR, 245 bp; (g3) Kehry, M., and Marcu, K.B. (1998). Efficient recombination of a
switch substrate retrovector in CD40- activated B lymphocytes: im-Ig3F and Cg3R, 323 bp; (g1) Ig1 and Cg1R, 429 bp; (g2b) Ig2bF and
Cg2bR, 371 bp; (g2a) Ig2aF and Cg2aR, 913, 678, and 560 bp; (e ) plications for the control of CH gene switch recombination. J. Immu-
nol. 161, 1336–1347.IeF and CeR, 392 bp; and (a) IaF and CaR, 497, 357, and 95 bp.
Postswitch transcripts were amplified using the following primer Burstein, H.J., Tepper, R.I., Leder, P., and Abbas, A.K. (1991). Hu-
pairs: (g3) ImF and Cg3R, 323 bp; (g1) ImF and Cg1R, 353 bp; (g2b) moral immune functions in IL-4 transgenic mice. J. Immunol. 147,
ImF and Cg2bR, 422 bp; (g2a) ImF and Cg2aR, 472 bp; (e) ImF and 2950–2956.
CeR, 285 bp; and (a) ImF and CaR, 267 bp. Germline and postswitch
Casellas, R., Nussenzweig, A., Wuerffel, R., Pelanda, R., Reichlin,transcripts were amplified by 30 cycles of PCR except e germline
A., Suh, H., Qin, X.F., Besmer, E., Kenter, A., Rajewsky, K., andtranscripts (34 cycles).
Nussenzweig, M.C. (1998). Ku80 is required for immunoglobulin iso-
type switching. EMBO J. 17, 2404–2411.DC-PCR
Chen, J., Lansford, R., Stewart, V., Young, F., and Alt, F.W. (1993).DC-PCR analysis was carried out as described (Chu et al., 1992).
RAG-2-deficient blastocyst complementation: an assay of geneGenomic DNA was isolated from spleen cells in AID2/2 mice before
function in lymphocyte development. Proc. Natl. Acad. Sci. USA 90,or after culture in vitro for 4 days with LPS and either IL-4 or TGFb.
4528–4532.After EcoRI digestion, genomic DNA was purified and self-ligated.
Ligated DNA was purified again and served as a template for PCR Chu, C.C., Paul, W.E., and Max, E.E. (1992). Quantitation of immuno-
using primers as reported previously for m-g1 (Chu et al., 1992) and globulin m-g1 heavy chain switch region recombination by a diges-
m-g2b (Ballantyne et al., 1998). tion-circularization polymerase chain reaction method. Proc. Natl.
Acad. Sci. USA 89, 6978–6982.
Somatic Hypermutation Assay Cogne, M., Lansford, R., Bottaro, A., Zhang, J., Gorman, J., Young,
VH186.2 transcripts were amplified from MLN cDNA from NP-CGG F., Cheng, H.L., and Alt, F.W. (1994). A class switch control region
immunized mice. VH186.2F-CmR and VH186.2F-Cg1R primer pairs at the 39 end of the immunoglobulin heavy chain locus. Cell 77,
were used for amplification of m and g1 transcripts, respectively. 737–747.
After 30 cycles of reaction using LA Taq polymerase (Takara Shuzo),
DiSanto, J.P., Bonnefoy, J.Y., Gauchat, J.F., Fischer, A., and dePCR products were cloned into pGEM-T vector (Promega) before
Saint Basile, G. (1993). CD40 ligand mutations in x-linked immunode-sequencing.
ficiency with hyper-IgM . Nature 361, 541–543.
Dunnick, W., Hertz, G.Z., Scappino, L., and Gritzmacher, C. (1993).PCR Primers
DNA sequences at immunoglobulin switch region recombination118: 59-GGCTGAGGTTAGGGTTCCATCTCAG-39; 119: 59-GAGGG
sites. Nucleic Acids Res. 21, 365–372.AGTCAAGAAAGTCACGCTGGA-39; ImF: 59-CTCTGGCCCTGCTTAT
TGTTG-39; Ig3F: 59-TGGGCAAGTGGATCTGAACA-39; Ig1: 59-GGC Essers, J., Hendriks, R.W., Swagemakers, S.M., Troelstra, C., de
CCTTCCAGATCTTTGAG-39; Ig2bF: 59-CACTGGGCCTTTCCAGAA Wit, J., Bootsma, D., Hoeijmakers, J.H., and Kanaar, R. (1997). Dis-
CTA-39; Ig2aF: 59-GGCTGTTAGAAGCACAGTGACAAAG-39; IeF: ruption of mouse RAD54 reduces ionizing radiation resistance and
59-TGGGATCAGACGATGGAGAATAG-39; IaF: 59-CCTGGCTGTTCC homologous recombination. Cell 89, 195–204.
CCTATGAA-39; CmR: 59-GAAGACATTTGGGAAGGACTGACT-39;
Friedberg, E.C., Feaver, W.J., and Gerlach, V.L. (2000). The many
Cg3R: 59-CTCAGGGAAGTAGCCTTTGACA-39; Cg1R: 59-GGATCC
faces of DNA polymerases: strategies for mutagenesis and for muta-
AGAGTTCCAGGTCACT-39; Cg2bR: 59-CACTGAGCTGCTCATAGT
tional avoidance. Proc. Natl. Acad. Sci. USA 97, 5681–5683.
GTAGAGTC-39; Cg2aR: 59-GCCACATTGCAGGTGATGGA-39; CeR:
Fukita, Y., Jacobs, H., and Rajewsky, K. (1998). Somatic hypermuta-59-CCAGGGTCATGGAAGCAGTG-39; CaR: 59-GAGCTGGTGGGAGT
tion in the heavy chain locus correlates with transcription. ImmunityGTCAGTG-39; VH186.2F: 59-TTCTTGGCAGCAACAGCTACA-39; G3:
9, 105–114.59-GGGCCAGCTCATTCCTCCACTC-39; 203: 59-ATGCCACTACCT
CTCTGGCCTTCA-39. Gellert, M. (1997). Recent advances in understanding V(D)J recombi-
nation. Adv. Immunol. 64, 39–64.
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